收藏切换
Improved Synthetic Process of Ruxolitinib Phosphate
收藏切换
Naihua ZHANG, Weichen CUI, Anguo ZHU, Hao WEN, Guimin ZHANG*
Chinese Journal of Pharmaceuticals | 2026, 57(2) : 167 - 172
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2026, 57(2): 167-172
• Paper •
Improved Synthetic Process of Ruxolitinib Phosphate
Full
Naihua ZHANG, Weichen CUI, Anguo ZHU, Hao WEN, Guimin ZHANG*
Affiliations
  • National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
Published: 2026-02-10 doi: 10.16522/j.cnki.cjph.2026.02.004
Outline
收藏切换

An improved synthetic process of ruxolitinib phosphate(1) was developed. Starting from(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl) methyl pivalate(2) and 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(3), [4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(5) was prepared via Suzuki-Miyaura coupling reaction. Compound 5 was deprotected by hydrochloric acid to afford [4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(6). Subsequent Michael addition of 6 with 3-cyclopentylacrylonitrile(4) furnished the racemic [4-[1-(2-cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(7). Chiral resolution of 7 using D-(+)-dibenzoyl-L-tartaric acid[D-(+)-DBTA] afforded (2S, 3S)-2,3-Bis(benzoyloxy) succinate salt of (R)-[4-[1-(2-cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(8). Deprotection and hydrolysis of 8 with sodium hydroxide yielded ruxolitinib(9). Finally, the target product 1 was available from 9 by salification reaction with phosphoric acid and recrystallization. The overall yield was 27% (based on 2), with the purity of 99.89% and the chiral purity of 99.88%, and the maximum single impurity less than 0.1%. The improved process features simple operation and has been verified by pilot-scale production, which was suitable for industrial production.

ruxolitinib phosphate  /  Janus kinase inhibitor  /  primary myelofibrosis  /  synthetic process
张乃华, 崔维琛, 朱安国, 文浩, 张贵民. 磷酸芦可替尼的合成工艺优化. 中国医药工业杂志, 2026 , 57 (2) : 167 -172 . DOI: 10.16522/j.cnki.cjph.2026.02.004
Naihua ZHANG, Weichen CUI, Anguo ZHU, Hao WEN, Guimin ZHANG. Improved Synthetic Process of Ruxolitinib Phosphate[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (2) : 167 -172 . DOI: 10.16522/j.cnki.cjph.2026.02.004
Year 2026 volume 57 Issue 2
145
38
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.02.004
  • Receive Date:2025-07-22
  • Online Date:2026-11-05
  • Published:2026-02-10
Article Data
Affiliations
History
  • Received:2025-07-22
Affiliations
    National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.02.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT